{"id":"NCT01121393","sponsor":"Boehringer Ingelheim","briefTitle":"BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)","officialTitle":"LUX-Lung 6: A Randomized, Open-label, Phase III Study of BIBW 2992 Versus Chemotherapy as First-line Treatment for Patients With Stage IIIB or IV Adenocarcinoma of the Lung Harbouring an EGFR Activating Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04-19","primaryCompletion":"2017-11-23","completion":"2017-11-26","firstPosted":"2010-05-12","resultsPosted":"2015-01-26","lastUpdate":"2018-12-14"},"enrollment":364,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung","Adenocarcinoma"],"interventions":[{"type":"DRUG","name":"Gemcitabine+Cisplatin","otherNames":[]},{"type":"DRUG","name":"BIBW 2992","otherNames":[]}],"arms":[{"label":"Arm A BIBW 2992","type":"EXPERIMENTAL"},{"label":"Arm B Chemotherapy","type":"ACTIVE_COMPARATOR"}],"summary":"To investigate the efficacy and safety of BIBW 2992 compared to standard first-line chemotherapy in patients with stage IIIB or IV adenocarcinoma of the lung harbouring an EGFR activating mutation","primaryOutcome":{"measure":"Progression-free Survival","timeFrame":"Tumour assessment were performed at screening, week 6, 12, 18, 24, 30, 36, 42, 48 and then every 12 weeks until progression or death whichever occurs first up to week 168","effectByArm":[{"arm":"Afatinib 40 Milligram (mg)","deltaMin":11.01,"sd":null},{"arm":"Gemcitabine / Cisplatin Chemotherapy","deltaMin":5.59,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":36,"countries":["China","South Korea","Thailand"]},"refs":{"pmids":["30584317","29653820","27601237","26823294","26051236","25589191","24439929"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":239},"commonTop":["Diarrhoea","Rash","Vomiting","Nausea","Decreased appetite"]}}